AI brief of an SEC Form 8-K · Idexx Laboratories (IDXX)

IDEXX director M. Anne Szostak to retire from board after May 12, 2026 annual meeting

Neutral Impact 2 of 5 leadership Written later

IDEXX Laboratories director M. Anne Szostak notified the company on February 13, 2026 that she will retire from the Board effective immediately after the 2026 Annual Meeting on May 12, 2026. The filing says her decision did not arise from any disagreement with the company or the Board, and the Board reduced the size of Class III upon her retirement without shrinking the overall Board, given the previously announced appointment of Michael G. Erickson, PhD, as a Class II member.

Key points

  • Director M. Anne Szostak, on the Board since 2012, will retire after the 2026 Annual Meeting on May 12, 2026
  • The filing states no disagreement with the company or Board on operations, policies or practices
  • Board reduced the size of Class III upon her retirement but kept overall Board size unchanged
  • Michael G. Erickson, PhD, previously announced, will join as a Class II member immediately after the 2026 Annual Meeting

The filing

CompanyIdexx Laboratories (IDXX)
Form8-K, current report
Filed with the SECFeb 13, 2026, 5:00 PM ET
Accession number0000874716-26-000007

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.